Company Overview and News

2
Are Investors Undervaluing Sotheby's (BID) Right Now?

2018-10-11 zacks
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.
CBSH CBSHP CBCB SGH BID

2
BID / Sotheby's 8-K (Current Report)

2018-09-12 sec.gov
Document
BID

3
Moving Average Crossover Alert: Sotheby's (BID)

2018-08-31 zacks
Sotheby's (BID - Free Report) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for BID broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness.
SCVL BIG BID PAYC

2
BID / Sotheby's 8-K (Current Report)

2018-08-29 sec.gov
Document
BID

90
Tracking Dan Loeb's Third Point Portfolio - Q2 2018 Update

2018-08-12 seekingalpha - 7
Dan Loeb's 13F portfolio value increased from $13.32B to $14.35B this quarter. The number of positions decreased from 40 to 38.
ATHTF STZ.B TWX CRM DOW DOV MELI PBF TPRE WP KDMN STZ UTX BKI TWC PVH DVMT FPAC.U GOOGL MSFT APY MHK TPNTF GRBK FB DOV.WI LEN NXPI PYPL NFLX BAX GOOG LEN.B MPC PAGS ADBE SPGI EGN MON ICE SHY CWH EA WYNN ANTM DWDP BID BLK V DHR ANTX

2
Sotheby's (BID) CEO Tad Smith on Q2 2018 Results - Earnings Call Transcript

2018-08-06 seekingalpha
Good morning, ladies and gentlemen, and welcome to the Sotheby's Second Quarter 2018 Earnings Conference Call. [Operator Instructions] As a reminder, ladies and gentlemen, this conference is being recorded. At this time, I would like to introduce Jennifer Park, Vice President of Investor Relations. Ms. Park, please go ahead.
BID

2
Sotheby's 2018 Q2 - Results - Earnings Call Slides

2018-08-06 seekingalpha
The following slide deck was published by Sotheby's in conjunction with their 2018 Q2 earnings call.
BID

18
Stocks Wobble As Trade Worries Ail Sentiment

2018-08-06 zacks
U.S. stock index futures were marginally lower on Monday. Strong performances by U.S. corporates in the second-quarter were overshadowed by lingering trade conflict between the United States and China. Berkshire Hathaway Inc.’s (BRK.B - Free Report) earnings per share for the second quarter 2018 were $4.87, up 182% year over year. Newell Brands Inc. (NWL - Free Report) , SeaWorld Entertainment Inc.
NWL SEAS BRK.A TSNU AAPL TSN BGSF BID

18
U.S. Stocks Marginally Lower On Monday

2018-08-06 zacks
U.S. stock index futures were marginally lower on Monday. Strong performances by U.S. corporates in the second-quarter were overshadowed by lingering trade conflict between the United States and China. Berkshire Hathaway Inc.’s (BRK.B - Free Report) earnings per share for the second quarter 2018 were $4.87, up 182% year over year. Newell Brands Inc. (NWL - Free Report) , SeaWorld Entertainment Inc.
NWL SEAS BRK.A TSNU AAPL TSN BGSF BID

2
BID / Sotheby's 10-Q (Quarterly Report)

2018-08-06 sec.gov
Document
BID

2
BID / Sotheby's 8-K (Current Report)

2018-08-06 sec.gov
Document
BID

2
Sotheby's Sees Hammer Chart Pattern: Time to Buy?

2018-07-24 zacks
Sotheby's (BID - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because BID recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
PRK BID CDNS

2
Sotheby’s Second Quarter 2018 Earnings Conference Call Invitation

2018-07-23 globenewswire
NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) -- Sotheby’s (NYSE:BID) will be holding its second quarter and six months ended June 30, 2018 earnings conference call on Monday, August 6, 2018 at 9:00 AM EDT. The call will be hosted by Tad Smith, President and Chief Executive Officer, and Mike Goss, Chief Financial Officer. The call will consist of a brief discussion by the Company followed by a question and answer period.
DTK BID

3
Why You Shouldn't Bet Against Sotheby's (BID) Stock

2018-07-06 zacks
One stock that might be an intriguing choice for investors right now is Sotheby’s (BID - Free Report) . This is because this security in the Auction and Valuation Services space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board.
ENPH BID

6
BID / Sotheby's 8-K (Current Report)

2018-07-02 sec.gov - 1
Document
BID

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to BID / Sotheby's on message board site Silicon Investor.

NXPI after Qualcomm failed bid NXPI after Qualcomm failed bid NXPI after Qualcomm failed bid Baidu (BIDU) Baidu (BIDU) Baidu (BIDU)
CENTRAL Rand Gold ( CRND ) Bidders Circling CENTRAL Rand Gold ( CRND ) Bidders Circling CENTRAL Rand Gold ( CRND ) Bidders Circling Bid /Ask Spreads - Market Manipulation Bid /Ask Spreads - Market Manipulation Bid /Ask Spreads - Market Manipulation
Discuss the Fiscal Cliff. Obamau0027s opening bid: $1.6 trillion Discuss the Fiscal Cliff. Obamau0027s opening bid: $1.6 trillion Discuss the Fiscal Cliff. Obamau0027s opening bid: $1.6 trillion Forbidden Technologies - Video technology and Google Forbidden Technologies - Video technology and Google Forbidden Technologies - Video technology and Google
UBID - an IPO spinoff of Creative Computers UBID - an IPO spinoff of Creative Computers UBID - an IPO spinoff of Creative Computers Sothebyu0027s (BID) Auction House Sothebyu0027s (BID) Auction House Sothebyu0027s (BID) Auction House
Carbon Monoxide Mortality and Morbidity Carbon Monoxide Mortality and Morbidity Carbon Monoxide Mortality and Morbidity Triangle Multi Media Inc. (QBID) Triangle Multi Media Inc. (QBID) Triangle Multi Media Inc. (QBID)
CUSIP: 835898107